1-9 of 9
Jingjing Feng
Close
Sort by
Journal Articles

A Multicenter Study of CAR-T Cell Therapy for Relapse of B-ALL Post Allogeneic Stem Cell Transplantation

Jingjing Feng, He Huang, Yongxian HU
Journal: Blood
Blood (2023) 142 (Supplement 1): 3485.
https://doi.org/10.1182/blood-2023-184740
Published: 2023
Journal Articles

Intracellular Retention of Tcrαβ/CD3 to Generate Novel Allogeneic CAR-T Cells (ThisCART19A) with Enhanced Antitumor Potency for Treating B-ALL

Yongxian HU, Guoqing Wei, Shan Fu, Pingnan Xiao, Jingjing Feng, Mingming Zhang, Xingbing Wang, Dongrui Wang, Jun Li, He Huang
Journal: Blood
Blood (2023) 142 (Supplement 1): 2111.
https://doi.org/10.1182/blood-2023-189052
Published: 2023
Journal Articles

Neither Conditioning Chemotherapy Nor GvHD-Prophylaxis: CD7 CAR-T Treatment Bridging to Haplo-HSCT

Yongxian Hu, Mingming Zhang, Tingting Yang, Ruirui Jing, Houli Zhao, Rongrong Chen, Tianning Gu, Pingnan Xiao, Ruimin Hong, Jingjing Feng, Shan Fu, Delin Kong, Huijun Xu, Jiazhen Cui, Simao Huang, Bin Liang, Guoqing Wei, Xiaolin Yuan, Qu Cui, Jiangtao Ren, Alex H. Chang, Dongrui Wang, He Huang
Journal: Blood
Blood (2023) 142 (Supplement 1): 1039.
https://doi.org/10.1182/blood-2023-185697
Published: 2023
Journal Articles

Dasatinib and CAR-T Cell Therapy for Newly Diagnosed Ph-Positive Acute Lymphoblastic Leukemia in Adults

Mingming Zhang, Yongxian Hu, Guoqing Wei, Shan Fu, Jingjing Feng, Ruimin Hong, Alex H. Chang, He Huang
Journal: Blood
Blood (2023) 142 (Supplement 1): 891.
https://doi.org/10.1182/blood-2023-186225
Published: 2023
Journal Articles

CD19/BCMA CAR-T Cell Therapy for Refractory Systemic Lupus Erythematosus - Safety and Preliminary Efficacy Data from a Phase I Clinical Study

Jingjing Feng, Yongxian HU, Alex H. Chang, He Huang
Journal: Blood
Blood (2023) 142 (Supplement 1): 4835.
https://doi.org/10.1182/blood-2023-186669
Published: 2023
Journal Articles

Fecal microbiota transplantation from young mice rejuvenates aged hematopoietic stem cells by suppressing inflammation

Xiangjun Zeng, Xiaoqing Li, Xia Li, Cong Wei, Ce Shi, Kejia Hu, Delin Kong, Qian Luo, Yulin Xu, Wei Shan, Meng Zhang, Jimin Shi, Jingjing Feng, Yingli Han, He Huang, Pengxu Qian
Journal: Blood
Blood (2023) 141 (14): 1691–1707.
https://doi.org/10.1182/blood.2022017514
Published: 2023
Includes: Supplemental data
Journal Articles

Safety and Efficacy of CD19 CAR-T Cells for Refractory Systemic Sclerosis: A Phase I Clinical Trial

Jingjing Feng, Yongxian Hu, Mingming Zhang, Heng Cao, Yini Ke, Huijun Xu, Jiazhen Cui, Yanlei Zhang, Alex Hongsheng Chang, Jin Lin, Guoqing Wei, He Huang
Journal: Blood
Blood (2022) 140 (Supplement 1): 10335–10336.
https://doi.org/10.1182/blood-2022-169265
Published: 2022
Journal Articles

Induced IL-17-Producing Γδt Cells Play a Protective Role in Intestinal Graft-Versus-Host Disease

Lin Xu, Jingjing Feng, MD, Yu Lin, PhD, Xiaoqing Li, He Huang, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4568.
https://doi.org/10.1182/blood-2018-99-119161
Published: 2018
Journal Articles

Profile of Capillary-Leak Syndrome in Patients Received Chimeric Antigen Receptor T Cell Therapy

Yongxian Hu, MD PhD, Jingjing Feng, MD, Mi Shao, He Huang, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5204.
https://doi.org/10.1182/blood-2018-99-117602
Published: 2018